These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4637899)

  • 1. Treatment of tardive dyskinesia. 3. Clinical efficacy of a dopamine competing agent, methyldopa.
    Kazamatsuri H; Cole JO
    Arch Gen Psychiatry; 1972 Dec; 27(6):824-7. PubMed ID: 4637899
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):95-9. PubMed ID: 4555831
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):100-3. PubMed ID: 4555826
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylphenidate in tardive dyskinesia.
    Fann WE; Davis JM; Wilson IC
    Am J Psychiatry; 1973 Aug; 130(8):922-4. PubMed ID: 4577471
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
    Kazamatsuri H; Chien CP; Cole JO
    Am J Psychiatry; 1973 Apr; 130(4):479-83. PubMed ID: 4570750
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic approaches to tardive dyskinesia. A review of the literature.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Oct; 27(4):491-9. PubMed ID: 4116201
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of methyldopa on tardive dyskinesia in psychogeriatric patients.
    Viukari M; Linnoila M
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):417-24. PubMed ID: 810301
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
    Ferrari P; Robotti E; Nardini M
    Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation of haloperidol by -methyldopa in the treatment of schizophrenic patients.
    Chouinard G; Serrano PM; Tetreault L
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):473-83. PubMed ID: 4198310
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 11. Amantadine in extrapyramidal syndromes induced by neuroleptic drugs.
    Dencker SJ; Lindberg D; Malm U
    Nord Psykiatr Tidsskr; 1973; 27(1):31-4. PubMed ID: 4687749
    [No Abstract]   [Full Text] [Related]  

  • 12. Tardive dyskinesia and the rabbit syndrome during wakefulness and sleep.
    Jus K; Villeneuve A; Jus A
    Am J Psychiatry; 1972 Dec; 129(6):765. PubMed ID: 4638729
    [No Abstract]   [Full Text] [Related]  

  • 13. Polygraphic studies of tardive dyskinesia and of the rabbit symdrome during different stages of sleep.
    Villeneuve A; Jus K; Jus A
    Biol Psychiatry; 1973 Jun; 6(3):259-74. PubMed ID: 4732255
    [No Abstract]   [Full Text] [Related]  

  • 14. Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.
    Simpson GM; Beckles D; Isalski Z; Lee JH
    J Clin Pharmacol New Drugs; 1972 Apr; 12(4):142-52. PubMed ID: 4553448
    [No Abstract]   [Full Text] [Related]  

  • 15. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H; Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse reactions to neuroleptic drugs.
    Vanĕcek J; Vinar O; Fink Z
    Act Nerv Super (Praha); 1978 Feb; 20(1):50-1. PubMed ID: 147599
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trial of tropatepine chlorhydrate as a corrector of syndromes due to neuroleptics].
    Delaunay J; Guibert S
    Ann Med Psychol (Paris); 1976 Jan; 1(1):144-7. PubMed ID: 970819
    [No Abstract]   [Full Text] [Related]  

  • 18. [Attempt at treatment of permanent type of post-neuroleptic dyskinesia].
    Villeneuve A; Böszörményi Z; Deschambault M; Lachance R
    Laval Med; 1970 Sep; 41(7):923-33. PubMed ID: 5509490
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention and management of tardive dyskinesia.
    Crane GE
    Am J Psychiatry; 1972 Oct; 129(4):466-7. PubMed ID: 5071149
    [No Abstract]   [Full Text] [Related]  

  • 20. Tardive dyskinesia.
    Simpson GM
    Br J Psychiatry; 1973 May; 122(570):618. PubMed ID: 4717040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.